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The expression of endogenous murine leukemia virus (MuLV) during develop- 
ment  and  throughout life in normal mice has been demonstrated serologically 
and  ultrastructurally  (1,  2).  In  addition,  experiments  have  indicated  that  a 
consequence  of this natural virus expression in the host is an  autogenous hu- 
moral imnmne response. Antibodies specific for virion and nonvirion antigens, 
Gross virus envelope antigen (GVEA) 1 and (;ross cell surface antigen (GCSA), 
respectively, have been detected in serum  and kidney eluates by immunoelec- 
tron microscopy, immunofluorescence, and complement fixation (3  7). In some 
strains of mice this chronic humoral immune response h~s an immunopathologic 
manifestation, as exemplified by glomerulonephritis. 
The  possible  ability  of  this  autogenous  immunity  to  regulate  virus- 
mediated pathogenesis may be a function of the qualit) and//or quantity of the 
humoral response. We have demonstrated (7) that antibodies specific for virion 
GVEA, as well as virus-neutralizing antibodies, can be detected in sera and in 
kidney, eluates of certain normal mice. Furthermore, the levels of virus-specific 
antibodies appear to be directly associated with age. The purpose of the present 
study was to evaluate the quantitative changes, with age, in the serum levels of 
free natural antibodies to MuLV antigen(s) in strains of mice with high and low 
natural incidences of lymphoma. To facilitate the detection and quantitadon of 
antibodies  directed  against  virion  GVEA,  we  have  utilized  a  radioimmune 
precipitation assay with radioactively labeled MuLV. 
Maleria{s amf Methods 
Animals.--Male B6C3F1 (C57BL/6  9  ;<  C3H/Anf  cO), BALB/c, and AKR mice from 
5-wk to 2-yr old were used in these studies. All animals were maintained in a specific pathogen- 
free animal facility. They were housed 8-10 per cage and were fed Purina Laboratory Chow 
(Ralston  Purina  Co.,  St.  Louis,  Mo.). 
* Research  supported jointly by  the  National Cancer  Institute  and  the  U.S.  Atomic 
Energy Commission under contract with the Union Carbide Corporation. 
American Cancer  Society postdoctoral fellow (PF-848). 
1 Abbreviations ~sed in this paper: GCSA, Gross cell surface antigens;  GVEA, Gross virus 
envelope antigens; MuLV,  murine leukemia virus; TNE, 0.05 M Tris--0.1 M NaCI--1 mM 
EDTA buffer. 
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Animals were bled by decapitation, and serum from each age group was pooled, except 
for occasional AKR mice that were handled individually. A standard serum pool derived from 
100  1.5-yr  old  B6C3F1  mice  was  obtained  by  drawing  blood  from  the  retroorbital  sinus. 
Original serum preparations were heat-inactivated at 56°C for 30 rain; however, since we could 
demonstrate that this did not influence reactivity of mouse serum in the radioimmune pre- 
cipitation assay, later serum preparations were divided and frozen at  -70°C without heat 
inactivation. 
Fischer rats  (specific pathogen-free) were bled from  the posterior vena cava,  and serum 
was heat-inactivated at 56°C for 30 mln and frozen at  --70°C. An aliquot of serum was ab- 
sorbed twice on monolayers of Swiss mouse embryo fibroblasts for 1 h. Rat anti-AKR virus 
serum  was  kindly  provided  by  Dr.  Roger  Wilsnack  (Huntington  Research  Laboratories, 
Baltimore,  Md.)  and  was  heat-inactivated  before  use.  Male  Syrian  Cr:RGH  hamsters 
(Sprague-Dawley Inc., Madison, Wis.) were bled  by decapitation, and  the serum was heat- 
inactivated  and  frozen  as  above. 
Cell Cultures.--Established  AKR  mouse  embryo  cell  cultures  [IIC2  (26a)]  were kindly 
provided by Dr.  Wallace P. Rowe (National Institutes of Health, Bethesda, Md.) and were 
maintained  on  Eagle's  minimum  essential  medium  supplemented  with  2  mM  glutaminc 
and  10%  fetal calf serum.  Two  subIines were derived in our laboratory; line 130 is a  high- 
passage culture that spontaneously initiated virus synthesis and line 75 is negative for virus 
synthesis. Normal Swiss 3T3M fibroblasts were obtained from Dr.  George Todaro  (National 
Cancer Institute,  Bethesda, Md.)  and were maintained as above. Continuous-passage Swiss 
mouse embryo cells chronically infected with Moloney leukemia  virus were derived in  this 
laboratory and maintained as above.  Stock cultures of the above cells were carried without 
antibiotics and were found free of mycoplasma. 
Preparation  of Radioactively Labeled Virus.--AKR  130 cells were plated into roller bottles 
and grown to confluency, with medium changes on alternate days.  12 h  before labeling,  the 
medium was changed to Eagle's minimal essential medium lacking leucine but supplemented 
with 2 mM glutamine and 1% fetal calf serum  (50  ml per bottle). For labeling,  the medium 
was  withdrawn  and  fresh medium  of  the  same  composition but  containing  50  #Ci/ml  of 
[3HJleucine  (53  Ci/mmo],  Schwarz/Mann  Div.,  Becton,  Dickinson,  and  Co.,  Orangeburg, 
N.  Y.)  was added.  After 12  h  the culture medium was collected, and fresh medium lacking 
isotope and leucine was added back. After an additional 12 h, the medium was again collected 
and the cells were discarded. The relatively short labeling time was used to assure that the 
virus preparations would contain intact virus particles.  The second harvest of medium in- 
creased  virus  yields considerably without  appreciably affecting the specific activity  of  the 
virus. Apparently because this is a  result of a  large cel]u]ar pool of viral proteins,  the radio- 
active components of which are not depleted until  12-18 h  after the termination of labeling 
(J.  N.  Ihle,  unpublished  observation). 
After each harvest the culture medium was clarified at 5,000 rpm in a  SorvaI1  CSA rotor 
(Ivan Sorvall, Inc., Newtown, Conn.) for 10 rain, and the virus was immediately concentrated 
by pelleting through 5 ml of 25% sucrose in a pH 7.5 buffer consisting of 0.05 M  Tris-0.1 M 
NaCI-1  mM EDTA  (TNE)  in a  Spinco SW27 rotor at 25,000 rpm for 1 h. The virus pellets 
were subsequently resuspended in  4  ml  of TNE,  immediately layered on a  15-60%  linear 
sucrose gradient  in  TNE,  and  further purified  by  isopycnic  banding in  a  Spinco SW25.1 
rotor  (Beckman Instruments, Inc.,  Spinco Div.,  Palo Ako,  Calif.)  at 25,000  rpm for  12  h. 
Gradients were fractionated into  1-ml aliquots on an Isco sucrose gradient fractionator, and 
aliquots  were  taken  for  determination  of  radioactivity.  The  virus  peak,  which  generally 
bands at a  sucrose concentration of 36%  (~1.16 g/cm  3 at 4°C),  was collected and a  sample 
was  taken  for  protein  determinations.  The  specific  activity  of  the  preparation  was  sub- 
sequently adjusted with unlabeled virus or with labeled virus with a  higher or lower specific 
activity, and the preparation was diluted with TNE to an appropriate concentration. Miquots 196  IMMUNITY  TO  ENDOGENOUS  IINA  TUMOR  VIRUS 
were frozen and stored at --70°C and were used immediately upon thawing. A typical profile 
of our virus preparations, obtained by isopycnic banding in a  sucrose gradient, is shown in 
Fig. 1. 
Preparation  of  Unlabeled Virus.---Nonradioactive  AKR  leukemia  virus  was  purified  as 
above from 12-h harvests of AKR cells grown in roller bottles in complete Eagle's minimal 
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Fro. 1.  Isopycnic sucrose gradient of labeled AKR  virus  used in  the radioimmune pre- 
cipitation assay. Centrifugation was in a  Spinco SW25.1  rotor at 25,000 rpm for 12 h, using 
a  5 ml sample on a  25 ml gradient of 25-60%  sucrose in TNE. The gradient was then frac- 
tionated into 1-ml aliquots, and the radioactivity was determined. 
essential  medium  supplemented with 2  mM  glutamine and  10%  fetal  calf  serum.  Protein 
concentrations were determined by the Lowry method (9). 
Radiolmmune Precipitation Assay.--The test serum  (0.2 ml)  was twofold serially diluted 
in TNE, 0.05 ml (6,000 cpm) of labeled virus was added, and the mixture was incubated 1 h 
at 37°C.  Subsequently,  an equal volume  (0.2  ml)  of antigIobulin  (Capel rabbit antfgamma 
globulin; either rat, mouse, or hamster) diluted 1:2 in TNE was added, and the mixture was 
incubated again at 37°C for 1 h and finally at 4°C for 2 h. "fhe precipitates were collected by 
centrifugation at  1,200  g for  10  min in an International Clinical centrifuge, and the super- 
natant was removed for determination of radioactivity. The pellets were washed three times 
in a  total of 3 ml TNE,  resuspended in 0.4 ml TNE, and prepared for counting. All samples 
were counted in 10  ml of "Aquasol"  (New  England Nuclear,  Boston, Mass.)  in a  Nuclear J.  N.  IIILE,  M.  YURCONIC,  JR.,  AND  M.  O.  HANNA,  JR.  197 
Chicago  scintillation  counter  (Nuclear-Chicago  Corp.,  Des  Plains,  ILL). Precipitation  is 
expressed  as the percentage of counts in the precipitate relative to the combined counts in the 
precipitate and first supernatant. 
A  number  of parameters  of  the  radioimmune precipitation  assay  were found  to  affect 
the results, including the quality and quantity of antimouse gamma globulin and the quality 
and quantity of radioactively labeled antigen. In general, the antiglobulin concentration does 
not change the titer of various antisera but does affect the extent of the reaction, particularly 
at high serum concentrations.  For example,  with a particular log of antiglobulin and mouse 
serum at a  1:32 dilution the amount of virus precipitated was reduced from 90% at a  1:4 
dilution  to  70%  at  a  1:8 dilution of antiglobulin.  In addition,  the reactivity of the anti- 
globulin can vary with different preparations.  To minimize this variation, each preparation 
of antiglobulin was tested with a standard mouse serum to determine the concentration that 
yielded the maximum precipitation of labeled antigen. Normally a  1:4 final dilution of anti- 
globulin was  optimal. 
The antigen concentration is also  critical. As expected,  titration at higher antigen con- 
centrations decreases  the titer of antibody. To minimize variations of results with virus prep- 
arations,  we  used  virus of a  constant  specific  activity,  which we obtained  by following a 
constant labeling regimen for virus preparations and by adjusting the specific activity of the 
preparation  as  described  above.  In  the  experiments  presented  here,  preparations  with  a 
specific activity of 3.0  X  107 cpm/mg protein were used.  In all assays we used 6,000  cpm 
(0.2 #g) of virus for each point, As a final control on individual virus preparations, each prep- 
aration was titered with a standard  serum to assure uniformity. 
The procedure for performing the titration can also  affect the results.  For example, we 
found it necessary  to wash the precipitates at least three times to remove spurious counts, 
particularly from serum with a low antibody titer. Moreover, dilutions of mouse serum beyond 
1:4,096  required  the  addition  of carrier mouse globulin for adequate  precipitation of any 
complexes formed; in general we did not use dilutions beyond this point. Lastly,  we noted 
only slight differences  in titrations when precipitates were allowed to form overnight at 4°C, 
as opposed to 2 h at 4°C, so we generally used the latter. 
We thank Dr. Barry L. Batzing for his helpful consultation regarding this work,  and Dr. 
Raymond W. Tennant for his assistance with the tissue cultures and for his helpful suggestions. 
RESULTS 
Typical  results  of the radioimmune  precipitation  assay  are shown in Fig. 2. In 
this experiment  a standard serum derived  from normal 1.5-yr  old B6C3FI mice 
was titrated against [*H]leucine-]abeled  MuLV isolated from  AKR 130 mouse 
embryo cells, which had spontaneously  initiated virus synthesis. At high anti- 
serum concentrations  (i :32 and 1:64) 90-95 %  of the radioactivity is precipi- 
tated, and  this percentage  drops  as  the  serum is diluted.  The increase  in per- 
centage precipitation  (79  90%)  between 1:2 and  1:32 dilutions is a  nonspecific 
interference at high serum protein concentrations and will be discussed below at 
greater length. In general, the slope of the line becomes linear with the log of the 
serum dilution when the percentage of the radioactivity precipitated is between 
80% and 20%. From these data,  titration of an antiserum can be defined as the 
reciprocal of the dilution that gives 50 % precipitation of the labeled antigen. 
To  determine  the  extent  of  nonspecific  trapping  during  precipitation,  we 
examined  the  ability of normal  hamster  serum  precipitated  with  rabbit  anti- 
hamster  gamma  globulin  to  cause  precipitation  of  the  radioactively  labeled 198  IMMUNITY  TO  ENDOGENOUS  RNA  TUMOR  VIRUS 
virus. As shown in Fig. 2, this serum does not cause significant precipitation of 
the labeled antigen. 
We have  also tested normal rat  serum for its ability to precipitate labeled 
virus in this assay, using rabbit  antirat gamma globulin. In  this case we ob- 
served  some  reactivity, but  the  activity was  removed  when  the  normal  rat 
serum  was  absorbed with  normal  mouse  fibroblasts before  the  assay. Under 
identical conditions, the immunological activity of specific rat anti-AKR virus 
serum is not affected by absorption of the serum with normal mouse fibroblasts, 
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FIG. 2.  Titration of standard B6C3F1 serum  (O--O) and normal hamster serum heated 
to 56°C for 30 min (©--O) with labeled AKR virus (specific activity, 3 X  107 cpm/mg). 
so we feel that  the  activity observed with normal rat serum represents a  rat 
antimouse heterophile and not a specific reaction against MuLV. 
To  characterize further  the  reaction  between  B6C3F1  serum,  AKR  Gross 
leukemia virus, and antiglobulin, we have analyzed the products of the reaction 
by isopycnic banding on sucrose gradients. As can be seen in Fig. 3, untreated 
virus bands close to the top of the gradient, whereas virus treated with B6C3F1 
serum at a  1:32 dilution bands slightly further into the gradient. These results 
suggest  that  the  virus  may  become  slightly  denser  after  reacting  with  the 
B6C3FI serum,  as would  be  expected if  specific antibody were  bound  to  the 
virus.  Finally, when  antiglobulin is added the  complex becomes too dense  to 
band isopycnically and is pelleted at the bottom of the centrifuge tube. Also, 
under  the conditions of the assay, treatment of the virus with B6C3F1  serum 
does not cause any dissociation of the virus. 
If the reaction is indeed  specific and  normal B6CJFx  serum  contains  anti- 
bodies against MuLV,  it should be possible to use  this serum  to detect virus J.  N.  IHLE,  M.  YURCONIC, JR.,  AND  1~.  G.  HANNA, JR.  199 
synthesis in  tissue-culture cells. This  observation  should  rule  out  a  spurious 
reaction with some normal AKR cell component that is purified with the virus. 
The results of such an experiment are shown in Fig. 4. In this experiment various 
cell lines were labeled with  [3HJleucine, and crude virus pellets were made by 
centrifuging the culture media over 25 % sucrose. The resuspended pellets were 
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FIG. 3.  Isopycnic sucrose gradients of labeled AKR virus (O--O), labeled AKR virus 
reacted with B6C3F1 serum  (O--©), and labeled AKR virus reacted with B6C3F1 serum 
and rabbit antimouse  gamma globulin  (&--A). Banding  was on a  5 ml 30-60%  sucrose 
gradient in a Spinco SW50.1 rotor at 40,000 rpm for 5 h.  The gradients were fractionated 
into 0.25-ml a]iquots  and the radioactivity was determined. 
subsequently assayed as above with the standard B6C3F1 serum at a  1:32 dilu- 
tion. As seen in Fig. 4,  significant precipitation of radioactivity was detected 
only in the AKR  130 line and in the Swiss mouse embryo MuLV line, known 
producers of virus; the low-passaged AKR 75 and the normal 3T3 lines, known 
nonproducers of MuLV,  showed no significant reactivity. 
We next examined the effect of addition of purified unlabeled virus on  the 
precipitation  of  labeled  virus.  In  these  experiments  we  used  the  standard 
B6C3F~  serum,  which  precipitates 82.5 %  and  79.5 %  of  radioactive virus  at 
1 : 128 and 1 : 256 dilutions, respectively. As can be seen in Fig. 5, the addition of 
increasing amounts of unlabeled virus to a  constant amount of antiserum and 
labeled virus progressively inhibits precipitation of the labeled virus. In addi- 200  IMMUNITY  TO  ENDOGENOUS  RNA  TIJ3IOR  VIRIJS 
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FIG. 4.  Detection  of virus synthesis by cultured  cells with B6C3F~ serum. One 100 mm 
plate each of AKR mouse embryo cells, lines 75  (nonproducers) and  130  (prcducers) NIH 
Swiss 3T3  fibroblasts,  and  Swiss mouse embryo  cells chronically  infected  with  Moloney 
leukemia virus were labeled with 500 #Ci of [~H]leucine in 10 ml of Eagle's minimal essential 
medium lacking lencine and supplemented with glutamine and 2% fetal calf serum. After 12 h 
the medium was collected, the virus was pelleted by centrifugation at 50,000 rpm for 1 h over 
1 ml of 25%  sucrose in TNE,  the pellet was resuspended in TNE, and  0.1  ml of B6C3F1 
serum was added. After  1 h at 37°C, 0.1  ml of antiglobulin was added and the mixture was 
incubated  at 37°C for 1 h and then at 4°C for 2 h. The pellet was collected by centrifugation, 
washed  five  times  with  TNE,  and  the  radioactivity  was  determined.  The  actual  counts 
precipitated  are shown by open bars, and the percentage of counts precipitated  by the B6C3F1 
serum relative to the total counts in the resuspended virus pellet is shown by the hatched bars. 
tion,  as the control antiserum is diluted the extent of inhibition becomes pro- 
gressively greater for any particular concentration of unlabeled virus. 
From  the  above  results,  we  conclude  that  the  reaction  between  normal 
B6C3Ft serum and radioactively labeled AKR MuLV is specific and indicative 
of an autogenous immunity to this virus. To explore further the development of 
autogenous  immunity  and  its  relation  to  the  pathogenicity  of  the  virus,  we 
examined  the  specific  antibody  levels of  three  strains  of  mice  with  different 
natural incidences of lymphoma, which presumably is a pathological expression 
of endogenous MuLV. 
In Fig. 6 we show the titration curves obtained from sera of B6C3F1 mice at 
various ages. At 5 wk before development of full immunological competence, the 
titer of antivirus activity is low and may in part represent maternal inheritance. 
By  12  wk,  however, the  titer was  increased  significantly, and  it continues  to J.  N.  II-ILE~ 3J'. YURCONIC,  JR.,  AND  M.  G.  HANNA~  JR.  201 
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Fie. 5.  Inhibition of precipitation of labeled AKR virus with BdC3FI serum by unlabeled 
AKR virus. B6C3F1 serum at dilutions of 1:128  (O--O) and 1:256  (O--O) was incubated 
for 1 h at 37°C with various concentrations of unlabeled AKR virus. Labeled virus was then 
added, and the radioimmune precipitation assay was performed. The B6C3F1 serum without 
unlabeled virus precipitates 82.5% and 79.5%  of the radioactive virus at dilutions of 1:128 
and  1:256,  respectively. 
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FI¢. 6.  Titration of sera from B6C3F1  animals of various ages by the radioimmune pre- 
cipitation assay. (O--O) 2 yr, (e--O)  1.5 yr, (A--z~) 1 yr; (A--A) 12 wk, (I~--[]) 5 wk. 202  IMMUNITY  TO  ENDOGENOUS  RNA  TUMOR  VIRUS 
increase at 1 yr, reaching an apparent maximum at 1.5 yr. At 2 yr, a decrease in 
the  titer of  the  serum is observed and  may reflect natural  senescence  of  the 
humoral immune system or a  decrease in free antibodies as a  result of an age- 
associated increase in virus burden. 
Fig. 7 illustrates the results obtained with normal BALB/c serum. As with 
B6C3F~ serum, the titer is initially low at 5 wk and increases to 1.5 yr of age. 
However, the levels of antibodies at all ages are considerably lower than those 
detected in the corresponding B6C3F, sera. 
In Fig. 8 we have plotted the results obtained with serum from various AKR 
mice. Unlike other samples tested, these sera show little, if any, precipitation of 
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FIG. 7.  "litration cf sera from BALB/c animals of various ages by the radioimmune  pre- 
cipitation assay. (C--C) 1.5 yr, (0-  Q) 1 yr, (~--&)5 wk. 
radioactivity  at  high  serum  concentrations.  There  is  some  precipitation  of 
radioactivity at intermediate  concentrations,  but  it never  reaches  the  extent 
observed with BALB/c or B6C3F1  serum.  Some inhibition of precipitation at 
the lower dilutions also occurs in 1- and 1.5-yr old BALB/c as well as 1-, 1.5-, 
and 2-yr old B6C3F1 serum titrations, but not to the extent observed with AKR 
sera. These results could be obtained if dissociation of the virus or nonspecific 
inhibition of the precipitation reaction occurred at high serum protein concen- 
tration. 
The first alternative was eliminated by the observation that treatment of the 
labeled virus with AKR serum does not render the radioactivity soluble after 
sedimentation  at  116,000  g  for  1  h.  To  assess  the  possibility of  some  non- 
specific interference, we examined the effects of various concentrations of AKR 
serum on precipitation of labeled virus by various dilutions of B6C3F1 serum 
(Fig. 9). As is evident, high concentrations of the AKR serum can effectively J.  N.  IHLE,  M.  YURCONIC~ JR.,  AND  M.  G.  HANNA~ JR. 
80 
203 
6O 
z  i..~Tn+h  .0RMAL 
_o  ye0r  SMALL  \ 
THYMOMA 
E_  4o 
,,o  / 
~"  \/  \"~8 week  NORMAL 
¢  ,eo LA +   l" 
20  THYMOMA-~-'.  /  l  ~.  \ 
oI  l:~t-'-"-?--  L  I  I  k  I  I 
o  2  4  +  ++  +a  +,+  +,++  a+c,  +~a 
t/SERUM DILUTION 
FIc. 8.  Titration of  sera  from various AKR  animals by  the radioimmune precipitation 
assay. (C--©) 8 wk, normal; (O--O) 8 too, normal; (A--~)  1 yr, small thymoma; (A--A) 
1 yr,  large  thymoma. 
inhibit  the  reaction with B6C3F1 serum, even at relatively high  levels of the 
latter serum. In addition,  the inhibition is essentially lost at a  1:16 dilution of 
AKR serum. At a limiting concentration of B6C3Ft serum (1:256), at which all 
of the labeled antigen is not precipitated, a significant stimulation of precipita- 
tion is evident, presumably reflecting the antivirus activity in the AKR serum. 
We attempted to alleviate this nonspecific interference by such  treatments as 
freeze-thawing of the serum, treatment with 2-mercaptoethanol, and centrifuga- 
tion at 116,000  g for 1 h before the  assay, none of which was effective. Never- 
theless, from our results we conclude that the extent of precipitation of labeled 
antigen detected beyond a  1 : 16 dilution of AKR serum reflects titratable anti- 
bodies, and that linear extrapolation of these lines back to 50% precipitation 
gives a reasonable value for the antibody titer. 
However, as is evident from the titration of AKR sera (Fig. 8), the level of 
titratable antibodies of normal AKR mice is drastically reduced relative to that 
of B6C3Ft or BALB/c mice. Of particular interest is the observation that an 
animal bearing a small thymoma had a  significantly reduced titer. Even more 
striking is the observation that an animal with a large thymoma had no demon- 
strable antibodies. These data suggest that the increased virus synthesis which 
accompanies the disease may deplete the autogenous antibodies. The composite 
results of these data are presented numerically in Table I. 
DISCUSSION 
The use of radioimmune precipitation for the detection and quantitation  of 
antibodies directed  against virus was first introduced by Gerloff et al.  (9)  to 204  IMMUNITY  TO  ENDOGENOUS  RNA  TUMOR  VIRUS 
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FIG. 9.  Effects of various concentrations of AKR serum from a  normal 8-mo old animal 
on  precipitation  of  labeled  AKR  virus  by  B6C3F1  serum  at  dilutions  of  1:256  (©--©), 
1:128  (O--O),  1:64  (fi~---Z~),  and  1:32  (A--A). 
measure  the  immune  response to polio  virus  after immunization.  Since  that 
time,  the methodology has been applied to a  number of similar problems in- 
volving immune responses to rabies (10)  and group A arboviruses (11). In those 
investigations, the radioimmune precipitation assay proved to be an extremely 
reliable,  quantitative  method for the detection  of antibodies directed  against 
virus. In the present  experiments, however, it was particularly important  to 
examine the specificity of the reaction. Our purpose was to examine an auto- 
genous response of the immune system to endogenous RNA tumor virus and to 
measure the extent of the reaction in mouse strains with high or low lymphoma 
incidences. That the reactions we observed are specific is suggested by several 
lines of evidence, including the nonreaction of mouse  cell-absorbed normal rat 
or normal hamster serum, the reaction of rat anti-AKR virus serum, inhibition 
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TABLE I 
Age-Associated Changes in Autogenous Immunity to Endogenous RNA-tumor  Virus 
Incidence of 
Radioimmune  leukemia and  Mean survival time;~  Strain  Age  precipitaton  titer*  lymphoma 
B6C3F1  5 wk  128 
12 wk  845  <5%  884 
1 yr  5,020 
l½ yr  8,450 
2 yr  2,160 
BALB/c  5 wk  20 
1 yr  317  <20%  733 
1½ yr  1,260 
AKR  8 wk  25 
8 mo  40  < 80%  402 
1 yr  40 
* Titrations  are  defined as  the reciprocal of the dilution  of antiserum  that gives 50% 
precipitation  of labeled AKR virus. 
:~ Data obtained from Davis et al.  (14). 
radioactivity only in tissue culture cells known to be producing virus,  and  iso- 
pycnic gradient dnalysis of the reaction products. 
We demonstrated by immunoelectron microscopy the existence of free  anti- 
bodies with specificity for vMon GVEA  in sera of B6C3F1 mice (7). Further- 
more, the specific serum antibodies, as well as antibodies eluted from dissociated 
immune complexes in kidney glomeruli, were capable of neutralizing AKR virus 
in vitro. Thus both the specificity and  the efficacy of the autogenous humoral 
immune response to "wild-type" RNA tumor virus are suggested from those re- 
sults. These studies also indicated that the extent of the autogenous immune re- 
sponse in B6C3F1 mice increases with age. This observation  was also  made in 
the  present  study; however,  the  radioimmune precipitation  assay provided  a 
much more sensitive quantitative measure of the increase. 
The sensitivity  of the  radioimmune  precipitation  assay relative  to in vitro 
neutralization  assays has been consistently noted.  For example,  Gerloff et al. 
(9)  showed the  precipitation  assay to be at  least  80  times more sensitive  for 
detection of antibodies  specific for polio virus than conventional in vitro neu- 
tralization tests. In the present study the radioimnmne precipitation assay was 
approximately 500-fold more  sensitive  than  XC  neutralization  assays,  which 
were  performed  with  the  same  standard  1  yr B6C3F1  serum. This  calcula- 
tion is based on a  comparison of the serum  titers  that gave 50 % reduction of 
the effect measured,  1:4 for neutralization activity vs. 1 : 2,048 for precipitation 
activity. 
The  results  presented  here  indicate  that  antibodies  directed  against  Gross 
virus particles do exist in normal mouse serum. The actual antigen(s)  involved 
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addition, since B6C3F1 serum reacts with only 5-10% of the radioactive com- 
ponents of disrupted virus, (J. N. Ihle, M. Yurconic, Jr., and M. G. Hanna, Jr., 
unpublished data), the antigens involved are apparently only a minor compo- 
nent of the virus, and they may represent one or more specific proteins. 
The observation that B6C3F~ serum can be used to detect virus synthesis in 
cultured cells not only constitutes evidence for the specificity of the reaction but 
also provides an extremely sensitive assay for virus synthesis in tissue culture. 
The question of the degree of relatedness of antigens of AKR virus and Moloney 
virus preparations is raised by our experiments. The serum of B6C3F~ mice was 
demonstrated  to precipitate both AKR and Moloney virus. In another study 
(7),  in  vitro  neutralization  of both viruses was  achieved with  the standard 
mouse serum. And it has been previously demonstrated that heterologous anti- 
sera to Gross virus can react to viruses of the Friend-Moloney-Rauscher group 
(12, 13). The question that remains is whether these viruses share some common 
envelope antigens or whether a  "wild-type" virus is propagated from infected 
cultures actively producing Moloney virus. 
Perhaps  the  most  significant  observation  presented  in  this  report  is  the 
marked difference in the autogenous immune response to endogenous leukemia 
virus in the three mouse strains tested. We are tempted to correlate the quanti- 
tati~e differences in  the  autogenous immune  response with  the difference in 
natural incidence of lymphoma (Table I). B6C3F1 and BALB/c mice of both 
sexes have relatively low lymphoma incidences, the mean survival times of the 
two strains being 884 and 733 days, respectively, whereas AKR mice have an 
extremely high incidence of lymphoma, with a mean survival time of 402 days 
(14). 
When  these parameters  are  evaluated,  a  number  of factors must  be  con- 
sidered,  including  the  quality  and  the  quantity  of  the  free antibodies.  For 
example, in the radioimmune precipitation assay we have measured reactivity 
to intact virus, but we have no evidence that the reactivity of serum from differ- 
ent strains of animals is directed against a common antigen. Thus, with AKR 
serum or kidney eluate the virus neutralization in vitro is weak (7), and previous 
reports suggest that the antibody specificity is primarily directed to the non- 
virion GCSA (3). On the other hand, B6C3F1 serum appears to react strongly 
with virion GVEA and has  strong  neutralization activity  in vitro (7). This 
question may be resolved in the future by examining the components of dis- 
rupted virus with which each serum reacts. 
A  second  consideration in  interpreting  these  results  is  that  the  observed 
quantitative differences could be due to differences in the level of antibody pro- 
duction or in the level of viral antigen burden. The levels of free antibodies in 
AKR mice may be a reflection of antibody complexing due to the high burden of 
endogenous virus and viral antigen. Support for this possibility is demonstrated 
by the comparison of virus-precipitating antibodies in comparably aged normal 
and thymoma-bearing AKR mice. The reduced levels of free antibodies in the J.  N.  IHLE,  M.  YURCONIC,  JR.,  AND  M.  G.  HANNA,  JR.  207 
mice with  small  and large thymomas can be attributed in part  to elevanted 
levels of virus and viral antigen contributed by the tumor. 
The results of Rowe et al. (15) strongly suggest that virus burden may be an 
important factor in the genetic regulation of virus expression in AKR mice. 
According to their report, genetic regulation is associated with the presence of 
the unexpressed form of the MuLV genome in all cells of the AKR embryo, 
resulting in an age-associated spontaneous induction and increasing infection of 
uninduced cells. Similarly, strains, such as BALB/c which have a low incidence 
of leukemia, do contain MuLV genetic material. In this case, however, while 
relatively large amounts of viral antigen and virus (16)  are induced, the virus 
particles are less infectious than those from AKR cultures (15). Therefore, in the 
case of AKR, the replicating antigen of a highly infectious virus could easily 
override a  specific humoral response. Thus the distinction between the func- 
tionality of the immune reaction and the genetic regulation of infectious virus is 
complicated, and generalizations regarding host functions in the regulation of 
RNA  tumor virus pathogenesis cannot be applied to all strains of mice. The 
point that remains, however, is that while a major consideration is presently 
made of the cellular control of endogenous virus expression, it is clear that there 
does exist a systemic mode of regulation exerted by the humoral immune sys- 
tem. 
SUMMARY 
The radioimmune precipitation assay using 3H-labeled AKR leukemia virus 
was  applied to  the detection  and  quantitation  of natural  serum  antibodies 
directed against endogenous murine leukemia virus (MuLV) envelope antigens 
B6C3F1 and BALB/c mice, which have low natural incidences of leukemia and 
lymphoma,  and  AKR  mice, which  have  a  high  incidence, were used  in  this 
study. Sera from mice of various age groups were assayed. A marked difference 
in  age-associated  levels  of  the  autogenous  immune  response  to  endogenous 
murine leukemia virus was detected, and  the quantitative differences among 
these strains were inversely related to the incidence of lymphoma. The radio- 
immune precipitation test as applied was 500 times more sensitive than virus 
neutralization. That the reactions we have observed are specific is suggested by 
several lines of evidence, including  the nonreactivity of normal hamster and 
absorbed rat serum, the positive reaction of absorbed rat anti-AKR serum, the 
inhibition  of precipitation  of  labeled  virus  by purified unlabeled  virus,  and 
isopycnic gradient analysis of the reactive products. 
We  thank  Dr.  Barry L.  Batzing for his helpful consultation regarding this work, and 
Dr. Raymond  W.  Tennant  for his assistance with the  tissue  cultures and  for  his helpful 
suggestions. 
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